Bizarre Patents
Apparatus for Simulating a High Five
A self-righting hand-arm configuration which is adapted to pivot when struck by a user, thereby simulating a "high five."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5376640 | Lipolytic enzyme inhibitors A method of inhibiting enzymatic hydrolysis of lipids in a mammal concerns orally administering an effective amount of a purothionin or an &3xb5;-polylysine of the formula: ##STR1## or a salt thereof, wherein n is a number of from 5 to 9, to a mammal... | 12/27/1994 |
| 5364636 | Inhibitor of absorption of digestion product of food and drink A drug for preventing the absorption of food materials dissolved during digestion, a drug for preventing obesity, a drug for treating hyperlipemia, a drug for treating diabetes mellitus, and a drug for preventing constipation, wherein the flocculant and o... | 11/15/1994 |
| 5340315 | Method of treating obesity A method of treating obesity comprises a screening phase, a reducing phase, an adaptive phase and a sustaining phase. The reducing and adapting phases involve the consumption of a weight loss beverage as a meal substitute for some meals. The method of tre... | 08/23/1994 |
| 5336486 | Appetite control method A method for suppressing appetite comprising administering by mouth to a subject an amount of polycarbophil that is effective to suppress the appetite of the subject without inducing a laxative effect in said subject.... | 08/09/1994 |
| 5322697 | Composition and method for inducing satiety A composition and method for the control of appetite having food grade nutrients as the active ingredients, and a pharmaceutically acceptable delivery agent, formulated so that the active ingredient is released predominantly in the ileum. The active ingre... | 06/21/1994 |
| 5300298 | Methods of treating obesity with purine related compounds There is disclosed a method of treating obesity in warm-blooded animals, including humans, as well as a method of increasing the muscle mass to fat ratio in farm animals. The methods entail administering to an animal in need thereof, an effective amount o... | 04/05/1994 |
| 5292753 | Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds The invention relates to the separation of enantiomers of cimaterol, (-)-cimaterol, the addition salts thereof and processes for preparing them and their use in pharmaceutical compositions and animal feeds.... | 03/08/1994 |
| 5292722 | Intravenous solution that diminishes body protein loss The present invention provides compositions and methods of decreasing the nitrogen loss in a mammal which is normally associated with the administration of isocaloric solutions. Specifically, the present invention provides compositions comprising from abo... | 03/08/1994 |
| 5286481 | Method of reducing weight in mammals Described is a method of decreasing the weight in mammals to a desired level comprising orally administering thereto an effective weight reducing amount of a non-toxic anion exchange resin containing composition for a desired period of time to achieve a d... | 02/15/1994 |
| 5268367 | Composition and method for lowering blood level of LDL-cholesterol A cholesterol or body weight regulating material comprising an enzyme resistant starch is disclosed. A composition which contains said enzyme resistant starch is also disclosed. A food, food material, and beverage, containing said enzyme resistant starch ... | 12/07/1993 |
| 5256697 | Method of administering pyruvate and methods of synthesizing pyruvate precursors A method for administering pyruvate is disclosed which comprises administering a therapeutically effective amount of a pyruvate precursor to a mammal in the form of pyruvamide or a pyruvyl-amino acid. The pyruvyl-amino acid is preferably selected from the... | 10/26/1993 |
| 5250572 | (R)-norfluoxetine in method for occupying serotonin IC receptors The present invention provides (R)-norfluoxetine and pharmaceutically acceptable salts thereof capable of selectively occupying 5HT1c receptors.... | 10/05/1993 |
| 5250571 | (S)-norfluoxetine in method of inhibiting serotonin uptake The present invention provides (S)-norfluoxetine and pharmaceutically acceptable salts thereof capable of inhibiting the uptake of serotonin.... | 10/05/1993 |
| 5246960 | Oxetanones Racemic compounds of the formula ##STR1## wherein R1, R2, R3, R4, R5 and n are as described herein, enantiomers and diastereomers thereof, and salts of these esters with weak acids, are described... | 09/21/1993 |
| 5225446 | Use of 1-deprenyl for retention of specific physiological functions 1-Deprenyl and pharmaceutically acceptable analog forms thereof are used at specific dosage levels and frequency of dosage to slow the normal age dependent deterioration of renal function, to provide increased exploratory behavior level of activity at any... | 07/06/1993 |
| 5223484 | Peptide which regulates weight gain in mammals A dodecapeptide for regulating weight gain in mammals, as defined in the sequence: CHHRKKGYADLY wherein C is cysteine, H is histidine, R is arginine, K is lysine, G is glycine, Y is tyrosine, A is alanine, D is aspartic acid and L is leucine; and the rema... | 06/29/1993 |
| 5221668 | Nutritional product for trauma and surgery patients A liquid nutritional product for trauma and surgery patients has a caloric density of about 1.2 to 1.5 Kcal/mL and a calorie to nitrogen ratio of about 112:1 to 145:1. A portion of the protein system comprises partially digested protein, and supplemental ... | 06/22/1993 |
| 5215750 | L-glutamine and vitamin-containing compositions effective for inducing weight loss and for weight control Compositions comprising L-glutamine in combination with vitamins, minerals, choline, and flavonoids are disclosed. Such compositions can be administered to effect weight reduction, or to aid in weight control.... | 06/01/1993 |
| 5204340 | Tetrahydrobenz(c,d)indole serotonin agonists This invention provides 6-substituted-4-(amino or substituted amino)tetrahydrobenz[c,d]indole serotonin agonists useful in treating a variety of conditions associated with serotonin function.... | 04/20/1993 |
| 5192804 | Carnitine-supplemented diet for starter pigs A feed composition containing L-carnitine and a high nutrient density diet is found to increase the lean-to-fat ratio of early weaned pigs. The L-carnitine is preferably reduced as the animal passes through its various stages of development, with initial ... | 03/09/1993 |
| 5175154 | 5 -pregnan-20-ones and 5-pregnen-20-ones and related compounds Compounds of the formulae: ##STR1## useful as anti-obesity, anti-diabetic, anti-coronary and hypolipidemic agents.... | 12/29/1992 |
| 5169852 | Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives Compounds of formula I are useful for suppressing appetite, and for altering macronutrient preferences, ##STR1## where the R2 -R9 substituents are so selected as to meet a defined quantitative structure activity relationship (QS... | 12/08/1992 |
| 5137716 | Method of reducing weight in mammals Described is a method of decreasing the weight in mammals to a desired amount comprising the steps of ingesting an effective weight reducing amount of a cholestyramine for a desired period of time to achieve a desired weight reduction. Compositions useful... | 08/11/1992 |
| 5126332 | Food compositions for the prevention of overeating Food compositions comprising a composition containing a water-soluble dietary fiber and protein with an isoelectric point in acidic region, contents of said water-soluble dietary fiber and said protein being in such a ratio as forming gel when an aqueous ... | 06/30/1992 |
| 5124328 | Morpholine derivatives compositions and use N-substituted-2-heterocyclic morpholine derivatives and compositions made therefrom are highly active compounds having utility as growth promotion agents for animals, bronchodilators, antidepressants and antiobesity agents.... | 06/23/1992 |
| 5097023 | -glucosidase inhibitors This invention relates to novel N-glycosyl derivatives of 1,4-dideoxy-1,4-imino-D-arabinitol, to the chemical processes for their preparation, to their -glucosidase inhibiting properties, and to their end-use application in the treatment of diabete... | 03/17/1992 |
| 5091524 | Glycosidase inhibitor salbostatin, process for its preparation, and its use Salbostatin, a compound of the formula I ##STR1## acts as a glycosidase inhibitor and is suitable for use in pharmacy and in plant protection.... | 02/25/1992 |
| 5055460 | Method for weight loss A method for producing or maintaining weight loss by administering to a human a composition containing an effective amount of each of caffine, aspirin and ephedrine. The pharmaceutical composition can be administered concurrently with caloric restriction ... | 10/08/1991 |
| 5023245 | Improved niacin formulation An antihyperlipidemic pharmaceutical or dietary supplement composition for oral use consisting essentially of a combination of niacin and a gel-forming dietary fiber, and a method of lowering cholesterol levels with such oral pharmaceutical composition, o... | 06/11/1991 |
| 5017619 | Phenethanolamine derivatives The invention is directed to phenethanolamine derivatives and their pharmaceutically compatible salts, having the formula ##STR1## wherein n is the number 1 or 2; L1 and L2 are hydrogen, C1-3 -(alkyl)carbonyl or C | 05/21/1991 |
| 5010061 | Guar flour The instant invention relates to guar flour formulations, to be ingested, wherein the formulations contain natural guar flour having a particle size diameter or 50 μm to 1500 μm and neither containing nor having been treated with any additive which subs... | 04/23/1991 |
| 5006517 | Treatment of Prader-Willi syndrome Prader-Willi Syndrome is alleviated by administering of a 3-oxo or hydroxy substituted 5-beta-androstan-17-one to an individual having the syndrome.... | 04/09/1991 |
| 4999341 | Appetite moderating and anti-gastritis composition The association of chitin or chitosan with soy saponins in an orally administered composition has appetite moderating and antigastritis activity. The objectionable side effects of the two active ingredients are also eliminated in the composition.... | 03/12/1991 |
| 4978669 | Method of suppressing appetite by administration of tetrahydro-beta-carboline derivatives Compounds of formula I are useful for suppressing appetite, for altering macronutrient preferences, for suppressing obsessive-compulsive behavior, and for inhibiting cravings and substance abuse: ##STR1## wherein R1 and R3 are e... | 12/18/1990 |
| 4965252 | Cholesterol-lowering combination compositions of guar gum and niacin An antihyperlipidemic pharmaceutical or dietary supplement composition for oral use consisting essentially of a combination of niacin and guar gum, and a method of lowering cholesterol levels with such oral pharmaceutical composition, or by the simultaneo... | 10/23/1990 |
| 4952567 | Inhibition of lipogenesis A process which comprises administering an antagonist of protein kinase C and/or the insulin receptor tyrosine kinase to a mammal in an amount therapeutically effective to inhibit lipogenesis in the mammal.... | 08/28/1990 |
| 4897390 | Novel anti-obesity compounds and method of use The present invention provides novel compounds for controlling mammalian obesity by simultaneous action upon caloric intake and caloric expenditure. This is accomplished by the administration of pharmaceutically acceptable and therapeutically active analo... | 01/30/1990 |
| 4892886 | Phenoxypropanolamines [p-[2-[[(S)-2-hydroxy-3-phenoxypropyl]amino]-ethyl]phenoxy]acetic acid and its physiologically compatible salts, which have catabolic activity and can be used for the treatment of obesity, of diabetes and of conditions which are associated with increased ... | 01/09/1990 |
| 4865850 | Dietary fat reduction A method and a composition for accumulating and the binding of food fats in an animal body gastrointestinal tract. The method and composition rely upon non-biodegradable collagen particles, such as microspheres, having a size of at least two microns and a... | 09/12/1989 |
| 4859468 | Compositions and method for decomposing adipose tissue Solvent extracts of Piper angustifolium and/or Boldea fragrans have excellent adipose tissue decomposing activity. These extracts, if administered in appropriate drug forms, provide effective remedy of corpulent constitution and if these extracts are added ... | 08/22/1989 |
